Reasonable-zone remains at 15% in Japan
This article was originally published in Clinica
Japan's "reasonable zone" for discounting Special Treatment Materials prices is to remain at 15%, under the revised reimbursement scheme effective this month. However, industry has had "no firm commitment from the Japanese government that the R-zone will stay at 15%" when the next round of reimbursement revisions takes place in 1998, US industry association HIMA told Clinica. As Clinica went to press, HIMA was testifying on Capitol Hill to a Ways and Means Committee on trade with Japan. The R-zone was one of the main issues under discussion.